Cytokinetics releases ESC 2026 late-breaking abstracts update

Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

0.00
  • Cytokinetics posted a press release outlining three late-breaking ESC Congress 2026 abstracts, led by ACACIA-HCM Phase 3 primary results for aficamten.
  • Hot Line presentation scheduled Aug. 28 in Munich; additional ACACIA-HCM analyses, MAPLE-HCM comparison set for Aug. 29.
  • Investor event planned at ESC to discuss the late-breaking presentations; timing, registration details to follow.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607070730PRIMZONEFULLFEED9757969) on July 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.